Barclays
TRIV

Barclays’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History

Barclays’s Portfolio TRIV Stock Details TRIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-13,569
Closed -$81K – 6804
2015
Q4 		$81K Buy
13,569
+4,149
+44% +$27.5K ﹤0.01% 4540
2015
Q3 		$47K Hold
9,420
– – ﹤0.01% 5047
2015
Q2 		$47K Buy
9,420
+9,200
+4,182% +$65.3K ﹤0.01% 5190
2015
Q1 		$2K Sell
220
-383
-64% -$3.95K ﹤0.01% 6936
2014
Q4 		$7K Buy
603
+526
+683% +$7.17K ﹤0.01% 6907
2014
Q3 		$1K Sell
77
-86
-53% -$1.25K ﹤0.01% 7597
2014
Q2 		$2K Buy
+163
New +$2.47K ﹤0.01% 7471

Barclays's TRIV Position: Q1 2016 in Review

Barclays sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q1 2016, closing a stake of 13,569 shares — an estimated $81K sold.

Barclays first reported a position in TRIV in Q2 2014 and held it in 7 quarters. The position peaked at $81K in Q4 2015. 0 funds tracked by Wall St. Rank hold TRIV as of Q1 2016.

  • Barclays reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q1 2016 after selling out during the quarter.
  • Barclays sold 13,569 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q1 2016, an estimated $81K.
  • Barclays first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q2 2014 and held it in 7 quarters.
  • Barclays's TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $81K in Q4 2015.
  • 0 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q1 2016.

Based on Barclays's 13F filing for Q1 2016, filed 16 May 2016.